ASCO 2019 | Waldenström’s macroglobulinemia: what options are available?

Name: Waldenström’s macroglobulinemia: what options are available?
Uploaded: 2019-06-03T00:00:00.000Z
Duration: 2 min 15 s
Description: Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, outlines the treatment options for patients with Waldenström’s Macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Jithma Abeykoon • 3 Jun 2019

ASCO 2019

Non-Hodgkin Lymphoma Rare Diseases Waldenström’s Macroglobulinemia Bendamustine Cyclophosphamide Dexamethasone Ibrutinib Rituximab

Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, outlines the treatment options for patients with Waldenström’s Macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.